NanoVibronix Inc (NAOV) USD0.001

Sell:$0.47Buy:$0.50$0.04 (8.01%)

Prices delayed by at least 15 minutes
Sell:$0.47
Buy:$0.50
Change:$0.04 (8.01%)
Prices delayed by at least 15 minutes
Sell:$0.47
Buy:$0.50
Change:$0.04 (8.01%)
Prices delayed by at least 15 minutes

Company Information

About this company

NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.

Key people

Brian M. Murphy
Chief Executive Officer, Director
Stephen Russell Brown
Chief Financial Officer
Harold Jacob
Chief Medical Officer, Director
Christopher M. Fashek
Independent Chairman of the Board
Aurora Cassirer
Independent Director
Michael Ferguson
Independent Director
Martin S. Goldstein
Independent Director
Thomas R. Mika
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US63008J6038
  • Market cap
    $3.36m
  • Employees
    10
  • Shares in issue
    6.14m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.